Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Rekvina Laboratories Ltd

NSE: VINRKLB · BSE: 526075 · Pharmaceuticals & Biotechnology · 22 announcements

Share price
₹51.51
Market cap
₹31.05 Cr
Revenue (annual)
₹1.27 Cr
Net profit (annual)
₹-0.25 Cr
P/E (TTM)
-91.4×Sector 47.4×
Promoter holding
77.00%+35.70% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:32 IST BSE
Annual General Meeting

Rekvina Laboratories Annual General Meeting

Rekvina Laboratories' 38th AGM will be held online on September 29, 2026. The board also approved the notice and noted the company secretary's resignation.

17:42 IST BSE
Annual General Meeting

Rekvina Laboratories Annual General Meeting

Rekvina Laboratories Limited announced the voting results of its Extra-Ordinary General Meeting held on April 10, 2026. Shareholders approved all six resolutions, including an authorized capital increase and a preferential share issue. The resolutions were passed with requisite majorities via remote e-voting and poll processes.

17:11 IST BSE
Annual General Meeting

Rekvina Laboratories Annual General Meeting

Rekvina Laboratories Limited held its first EGM of FY2026-27 on April 10, 2026. Shareholders considered resolutions including increasing authorized share capital, altering the Memorandum and Articles of Association, and approving preferential equity allotments for cash and non-cash consideration. The meeting concluded with 17 members present and voting conducted via polling papers.